结直肠癌肝转移瘤周围肝实质的MRI表现:长期预后的潜在预测指标
本回顾性研究纳入2008年7月至2015年6月间未行新辅助化疗、根治性手术前接受钆塞酸二钠增强MRI的106例结直肠癌肝转移患者(148个病灶),评估瘤周早期强化、钆塞酸二钠摄取减低及胆管扩张,并与病理血管侵犯及长期预后进行关联分析。结果显示瘤周胆管扩张与病理门静脉侵犯、胆管侵犯及较差的无复发生存期和总生存期相关,瘤周信号改变可预测根治性术后的长期预后。
要点
- 瘤周胆管扩张预测病理门静脉侵犯的敏感度24%、特异度91%,预测胆管侵犯的敏感度42%、特异度90%。
- 瘤周胆管扩张与较差无复发生存期相关(HR=2.4,95%CI:1.3,4.2;P=.03)。
- 瘤周胆管扩张与较差总生存期相关(HR=2.4,95%CI:1.2,4.9;P=.01)。
核心结论
- 结直肠癌肝转移瘤周围肝实质的MRI信号强度改变可预测未行新辅助化疗患者根治性手术后的长期预后。
研究设计与样本
- 回顾性研究,纳入2008年7月至2015年6月间根治性手术前接受钆塞酸二钠增强MRI、未行新辅助化疗的结直肠癌肝转移患者106例(148个病灶),中位随访60个月(范围9-127个月)。
- 由三名腹部放射科医生评估瘤周早期强化、钆塞酸二钠摄取减低及胆管扩张,并对所有肿瘤标本重新评估门静脉、肝静脉及胆管侵犯情况。
- 采用Cox比例风险模型结合贝叶斯信息准则筛选无复发生存期和总生存期的预测因素,并将既往报道的预后因素纳入多变量分析。
关键影像表现/征象
- 结直肠癌肝转移瘤周围出现胆管扩张。
- 结直肠癌肝转移瘤周围出现早期强化。
- 结直肠癌肝转移瘤周围出现钆塞酸二钠摄取减低。
诊断标准与关键数值
- 瘤周胆管扩张预测病理门静脉侵犯:敏感度12/50(24%),特异度89/98(91%),P=.02。
- 瘤周胆管扩张预测病理胆管侵犯:敏感度8/19(42%),特异度116/129(90%),P=.001。
- 瘤周胆管扩张预测较差无复发生存期:P=.03,HR=2.4(95%CI:1.3,4.2)。
- 瘤周胆管扩张预测较差总生存期:P=.01,HR=2.4(95%CI:1.2,4.9)。
- 瘤周早期强化和钆塞酸二钠摄取减低与胆管扩张组合预测较差总生存期:P=.001,HR=3.3(95%CI:1.6,6.8)。
临床应用与阅片要点
- 在钆塞酸二钠增强MRI阅片时,应关注结直肠癌肝转移瘤周围肝实质是否出现胆管扩张,该征象与病理门静脉侵犯、胆管侵犯及较差的无复发生存期和总生存期相关。
- 瘤周早期强化和钆塞酸二钠摄取减低单独在多变量分析中被变量选择剔除,但二者与胆管扩张组合可预测较差总生存期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI is superior to CT in the detection of colorectal liver metastases (CRLMs) smaller than 10 mm. However, few studies have used MRI findings to predict patients' long-term prognosis. Purpose To investigate the relationship between Gd-EOB-DTPA-enhanced MRI findings in the liver parenchyma peripheral to CRLM and both pathologic vessel invasion and long-term prognosis. Materials and Methods This retrospective study included patients who underwent Gd-EOB-DTPA-enhanced MRI before curative surgery for CRLM, without neoadjuvant chemotherapy, between July 2008 and June 2015. Early enhancement, reduced Gd-EOB-DTPA uptake, and bile duct dilatation peripheral to the CRLM at MRI were evaluated by three abdominal radiologists. All tumor specimens were reevaluated for the presence or absence of portal vein, hepatic vein, and bile duct invasion. Predictors of recurrence-free survival (RFS) and overall survival (OS) after surgery were identified with Cox proportional hazard model with the Bayesian information criterion. Previously reported prognosticators were selected for multivariable analyses. The median follow-up period was 60 months (range, 9-127 months). Results Overall, 106 patients (mean age, 65 years ± 12 [standard deviation]; 68 men) with 148 CRLMs were evaluated. Bile duct dilatation peripheral to the tumor was associated with pathologic portal vein invasion (sensitivity, 12 of 50 [24%]; specificity, 89 of 98 [91%]; P = .02), bile duct invasion (sensitivity, eight of 19 [42%]; specificity, 116 of 129 [90%]; P = .001), poor RFS (P = .03; hazard ratio [HR] = 2.4 [95% confidence interval {CI}: 1.3, 4.2]), and poor OS (P = .01; HR = 2.4 [95% CI: 1.2, 4.9]). For RFS and OS, early enhancement and reduced Gd-EOB-DTPA uptake peripheral to the CRLM were eliminated by means of variable selection in the multivariable analysis, but the combination of these findings with bile duct dilatation provided a predictor of poor OS (P = .001; HR = 3.3 [95% CI: 1.6, 6.8]). Conclusion MRI signal intensity changes peripheral to the colorectal liver metastasis were predictors of long-term prognosis after curative surgery without neoadjuvant chemotherapy. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Bashir in this issue.
引用
- Nakai Y, Gonoi W, Kurokawa R, et al. MRI Findings of Liver Parenchyma Peripheral to Colorectal Liver Metastasis: A Potential Predictor of Long-term Prognosis. Radiology. 2020. PMID: 33021892. doi:10.1148/radiol.2020202367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。